Cargando…
Use of mepolizumab in adult patients with cystic fibrosis and an eosinophilic phenotype: case series
BACKGROUND: Cystic fibrosis (CF) is characterized by inflammation, progressive lung disease, and respiratory failure. Although the relationship is not well understood, patients with CF are thought to have a higher prevalence of asthma than the general population. CF Foundation (CFF) annual registry...
Autores principales: | Zhang, Lijia, Borish, Larry, Smith, Anna, Somerville, Lindsay, Albon, Dana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945791/ https://www.ncbi.nlm.nih.gov/pubmed/31921321 http://dx.doi.org/10.1186/s13223-019-0397-3 |
Ejemplares similares
-
Association between Cystic Fibrosis exacerbations, lung function, T2 inflammation and microbiological colonization
por: Albon, Dana, et al.
Publicado: (2023) -
Experience with mepolizumab in adults with severe eosinophilic asthma: a case series from India
por: Maturu, Venkata Nagarjuna, et al.
Publicado: (2021) -
Mepolizumab use in cystic fibrosis‐associated allergic bronchopulmonary aspergillosis
por: Boyle, Maeve, et al.
Publicado: (2020) -
Impact of elexacaftor/tezacaftor/ivacaftor on depression and anxiety
in cystic fibrosis
por: Zhang, Lijia, et al.
Publicado: (2022) -
The Impact of CFTR Modulator Triple Therapy on Type 2 Inflammatory Response in Patients with Cystic Fibrosis
por: Mehta, Ajay, et al.
Publicado: (2023)